Bioheart, Inc., Added to Russell Microcap Index
Bioheart, Inc. (Nasdaq: BHRT) a biotechnology company that is focused on the development of autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart damage, today announced it has been added to the Russell Microcap Index after the Russell Investment Group reconstituted its comprehensive set of U.S. and global equity indexes on June 27, 2008.Feed :
MiamiHerald.com: Press Releases - Medical
| Updated : 3 months ago
0 Comments Add or View Comment







Google
Netvibes
Yahoo
Technorati